Epigenetic Instability in Embryonic Stem Cells by Horii, Takuro & Hatada, Izuho
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 14
Epigenetic Instability in Embryonic Stem Cells
Takuro Horii and Izuho Hatada
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/54367
1. Introduction
Embryonic stem (ES) cells constitute a very important tool for regenerative medicine today.
Human ES cells, in particular, are almost all derived from embryos obtained by in vitro fer‐
tilization (IVF) followed by in vitro culture (IVC); however, such in vitro manipulated em‐
bryos often show epigenetic abnormalities in imprinted genes that can lead to the
development of various diseases. We recently reported that epigenetic differences occurred
between ES cells derived from in vivo developed embryos (Vivo ES) and ES cells derived
from in vitro manipulated embryos (Vitro ES) [1]. In addition, we found that the DNA meth‐
ylation state of uniparental and somatic cell nuclear transfer (SCNT) ES cells exhibits epige‐
netic instability during in vitro culture [2]. In this chapter, we review studies that have
examined the epigenetic instability of ES cells during generation and maintenance cultures,
and discuss the candidate factors that may be responsible for this epigenetic instability.
2. Epigenetic regulation by DNA methylation
In vertebrate genomic DNA, the 5' cytosine residues in CpG sequences are often methylated
[3]. DNA methylation plays an essential role in the normal development of mammalian em‐
bryos by regulating gene expression through genomic imprinting and X chromosome inacti‐
vation, and confers genomic stability [4-7]. In this chapter, we focus primarily on genomic
imprinting, which is the preferential silencing of one of the parental alleles of a gene by epi‐
genetic DNA methylation since epigenetic modifications to some imprinted genes cause dis‐
eases such as Beckwith-Wiedemann syndrome and Prader-Willie syndrome. For example,
the expression level of the H19 imprinted gene is regulated by an upstream differentially
methylated region (DMR), and epigenetic alterations to the DMR result in Beckwith-Wiede‐
mann syndrome [8-10]. The H19 mRNA is transcribed from the unmethylated maternal al‐
© 2013 Horii and Hatada; licensee InTech. This is an open access article distributed under the terms of the
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lele but is not transcribed from the methylated paternal allele (Fig. 1). In contrast, DMRs of
Peg1 (Mest), Snrpn and Igf2r are methylated in the maternal allele and unmethylated in the
paternal allele. Genomic imprinting is very stable except for the period when the reprogram‐
ming of genomic imprinting takes place in germline cells [11]. For the establishment and
maintenance of DNA methylation, the cytosine-guanine (CpG) DNA methyltransferases
(Dnmts), Dnmt1, Dnmt3a, and Dnmt3b, are the main factors that coordinately regulate CpG
methylation in the genome [12-14]. Dnmt1 is involved in maintenance activity, while
Dnmt3a and Dnmt3b are responsible primarily for the creation of new methylation patterns.
Figure 1. Regulation of gene expression in the H19 imprinted gene.
3. Epigenetic instability in preimplantation embryos
In general, ES cells, especially human ES cells, are generated from blastocyst stage embryos
that are produced by in vitro manipulations such as IVF and IVC. However, in vitro manipulat‐
ed embryos may already possess epigenetic abnormalities because the culture conditions of
fertilized embryos can influence the methylation state. For example, a sub-optimal culture me‐
dium (e.g., Whitten’s medium) can cause aberrant genomic imprinting of the H19 gene [15],
and culture medium supplemented with fetal calf serum alters mRNA expression of imprinted
genes [16]. Our recent study suggests that altered DNA methylation due to IVC conditions oc‐
curs not only in imprinted genes but also in genome-wide repetitive sequences, such as major
and minor satellite sequences [17]. Thus, alteration of DNA methylation can occur in response
to various factors, from the moment when embryos are collected from the oviducts or uterus.
4. Epigenetic instability in ES cells during prolonged culture
ES cells are established from the inner cell mass (ICM) of blastocyst stage embryos [18,19]. Once
ES cell lines are established, they can be maintained for long periods of time and used for sever‐
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al applications. However, ES cells lose their pluripotency during prolonged in vitro culture
[20]. Several studies indicate that the accumulation of epigenetic alterations over time is corre‐
lated with the loss of pluripotency in ES cells. Dean et al. reported that epigenetic alterations
that occur in ES cells persist to later developmental stages and are associated with aberrant
phenotypes in completely ES cell-derived mice [21]. Humpherys et al. show that variation in
imprinted gene expression is observed in most cloned mice derived from ES cell donors, even
those derived from ES cells of the same subclone [22]. Such epigenetic drift of imprinted genes
was also observed in our experiments during prolonged culture of mouse ES cells (Fig. 2): DNA
methylation of four imprinted genes, Peg1, Snrpn, Igf2r and H19, was unstable during cell cul‐
ture (P3-30), even in the same cell line, over time. Minoguchi and Iba reported that retroviral
DNA that is introduced into mouse ES cells is progressively silenced by DNA methylation;
however, a substantial amount of retroviral DNA is reversibly reactivated by DNA demethyla‐
tion [23]. Such epigenetic drift has also been observed in human ES cells, depending on the
method of establishment and the culture conditions [24].
Figure 2. Epigenetic drift of imprinting methylations in fertilized embryo-derived ES cells. A. Combined bisulfite restriction
analysis (COBRA) was conducted for three fertilized embryo-derived ES cell lines (B6-2, B6-6 and B6-8) during prolonged in
vitro culture (P3, P10 and P30). The maternally methylated imprinted genes Peg1, Snrpn and Igf2r, and the paternally me‐
thylated imprinted gene, H19, were examined. B. Summary of imprinting methylations during prolonged culture of ES
cells. dig, digestion by restriction enzymes; u, unmethylated PCR products; m, methylated PCR products.
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5. Epigenetic differences between male and female ES cells
Large differences in epigenetic  drift  have been observed between male (XY) and female
(XX)  mouse  ES  cells.  Global  demethylation,  including  imprinted  genes  and  satellite  re‐
peats,  occurred  more  frequently  in  female  ES  cell  lines  compared to  male  ES  cell  lines
[21,  25].  This  global  demethylation  reflects  the  number  and state  of  X  chromosomes  in
ES cells. In general, both X chromosomes are active in female ES cells, whereas male ES
cells have only one active X chromosome. The X chromosome state in female ES cells is
thought  to  lead  to  downregulation  of  DNA  methyltransferases  (Dnmt3a  and  Dnmt3b)
and,  ultimately,  to  global  hypomethylation  [25].  Thus,  DNA  methylation  of  imprinted
genes  and  repetitive  sequences  are  gained  or  lost  at  high  rates  even  in  clonal  popula‐
tions of ES cells, and these alterations may have deleterious effects on phenotypes of ES
cell-derived animals or tissues.
6. Epigenetic differences between vivo and vitro ES cells
6.1. Methylation state of vivo and vitro ES cells
In human ES cells, several studies have recently provided evidence for the efficient induc‐
tion of endoderm, mesoderm, and ectoderm, and many of their downstream derivatives
[26], and these reports offer broad possibilities for regenerative medicine. However, all hu‐
man ES cell lines are established from in vitro manipulated embryos that often show abnor‐
mal genomic imprinting, which can lead to an increase in the frequency of diseases.
Therefore, we have compared the methylation state of imprinted genes and the gene expres‐
sion patterns of both Vivo and Vitro ES cell lines in mice [1].
Although the genomic imprinting is maintained during preimplantation development, nor‐
mal imprinting can occasionally be disrupted in preimplantation embryos during IVC, re‐
sulting in biallelic expression of the H19 gene [15,27]. To investigate whether Vitro ES cells
take on abnormal imprinting from IVC blastocysts, we performed methylation analysis of
the H19 DMR for early passage (P2) cells (Fig. 3). COBRA analysis shows that the H19 DMR
is significantly demethylated in Vitro ES cells compared to Vivo ES cells. The Igf2r DMR2
also showed significant differences among Vitro vs. Vivo ES cells, but significant differences
in the methylation of Snrpn and the major satellite repeats were not detected.
In additional experiments, both Vivo and Vitro ES cells were passaged several more times,
and the methylation state of imprinted genes and satellite repeats was investigated at later
passages (P5) (Fig. 3). Results from COBRA analysis at P5 showed no significant differences
between Vivo and Vitro ES cells. Even Vivo ES cells exhibited highly demethylated alleles.
In contrast, some Vitro ES cells had an almost normally methylated allele. This result indi‐
cates that the methylation state of ES cells at later passages depends more on the character of
the individual cell lines than on the origin of the ES cells.
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6.2. Gene expression of vivo and vitro ES cells
We assessed gene expression patterns in ES cells at early and late passages by quantitative
real-time RT-PCR. The expression of Oct3/4 mRNA, a pluripotent cell marker, was signifi‐
cantly higher in early passage Vivo ES cells than in Vitro ES cells, whereas other pluripotent
marker genes, Nanog and Stella, showed no significant differences in expression levels be‐
tween the two types of ES cells. Among the methylation-related genes, mRNA expression of
the de novo DNA methyltransferase, Dnmt3b, was significantly higher in Vivo ES cells. Ex‐
pression of growth arrest and DNA damage-inducible protein 45 beta (Gadd45b), which is a
putative demethylation factor [28,29], is higher in Vitro ES cells. Thus, mRNA expression
patterns of several methylation-related genes tended to shift, resulting in the promotion of
demethylation and the inhibition of methylation in Vitro ES cells. In contrast, at later passag‐
es, no significant differences between Vivo and Vitro ES cells were found with respect to the
pluripotent marker genes and methylation-related genes that were examined.
Figure 3. Epigenetic differences between Vivo and Vitro ES cells. DNA methylation status of imprinted genes, H19,
Snrpn and Igf2r, and major satellite repeats were examined by COBRA in each ES cell line at an early passage (P2) and
a later passage (P5). These graphs summarize previously reported data [1]. *, P < 0.05.
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7. Epigenetic instability in SCNT and uniparental ES cells
7.1. SCNT ES cells
Maintenance of the normal epigenetic state in SCNT-ES cells is crucial for their use in thera‐
peutic applications. We established two SCNT-ES cell lines from embryos that were pro‐
duced by introducing mouse embryonic fibroblast (MEF) donor cells into enucleated
oocytes. Only two ES cell lines were generated by SCNT, which give a small sample size to
examine, but the DNA methylation state of imprinted genes seems to be more severely al‐
tered compared to normal ES cell lines at early passages (Fig. 2 and Fig. 4). The abnormal
DNA methylation in SCNT-ES cells undergoes further changes during prolonged culture
(P10 and P30). For example, the imprinting methylation of the Snrpn gene has been com‐
pletely lost in both the Nt-1 and Nt-2 lines, and that of the H19 gene has been completely
lost in the Nt-1 line (Fig. 4). Chang et al. reported that the H19 imprinted gene displays dis‐
tinct abnormalities both in SCNT-ES and fertilized embryo-derived ES cell lines after long-
term culture in vitro, and both exhibit indistinguishable DNA methylation patterns of the
imprinted gene [30]. Nevertheless, methylation imprints vary widely in cultured donor cells
and their derivative cloned mice, even across the same subclone of donor cells [22]. In fact,
results from previous studies indicate that the methylation state of imprinted genes is fre‐
quently disrupted in SCNT embryos and their derivative cloned animals [31,32]. In addition,
the process of nuclear transfer itself could alter the DNA methylation and gene expression
[33]. Thus, the epigenetic marks in SCNT-ES cells may potentially be varied and altered
compared to normal ES cells, at least in early passages.
7.2. Uniparental (parthenogenetic) ES cells
We and other groups have suggested that parthenogenetic ES (PgES) cells may be a plu‐
ripotent stem cell that could serve as a source of tissue for transplantation [34-36]. PgES
cells  do not require the destruction of  viable biparental  embryos as do normal ES cells.
In addition, PgES cells do not need viruses or expression plasmids for the establishment
of  iPS cells.  These are  very powerful  advantages for  therapeutic  applications.  However,
the biased epigenetic status and poor pluripotency of parthenogenetic cells are major is‐
sues  to  be  overcome.  PgES cells  are  established from parthenogenetic  embryos  that  are
produced by the artificial activation of the oocyte. Therefore, PgES cells that possess only
maternal  genomes  could  exhibit  biallelic  or  silenced  expression  of  imprinted  genes,
which  causes  poor  pluripotency.  Indeed,  parthenogenetic  embryos  show  poor  growth
and restricted tissue contribution in chimeras [37,38]. However, established PgES cells ex‐
hibit an improved contribution to chimeras, compared to chimeras derived from parthe‐
nogenetic  embryos  [39].  Recent  reports  have  shown that  loss  of  imprinting  occurred in
PgES cells  and derivative  somatic  cells  in  chimeras  and led to  changes  in  the  gene ex‐
pression  of  imprinted  genes  and  improved  pluripotency  [2,40].  For  example,  Peg1  and
Snrpn  genes are originally silenced in parthenogenetic cells,  whereas expression of these
genes  is  elevated  in  PgES  cells  by  demethylation  of  the  DMR  of  each  gene.  PgES  cell
lines that were reprogrammed by loss of imprinting are closest to normal ES cell lines in
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terms of gene expression pattern and pluripotency. Thus, reprogrammed PgES cells will
provide a good tool for therapeutic applications. This is a case in which epigenetic insta‐
bility  in  ES  cells  resulted  in  a  desirable  outcome.  However,  epigenetic  instability  in  ES
cells most often leads to undesirable results.
Figure 4. Epigenetic instability in SCNT-ES cells during prolonged culture. Methylation in two SCNT ES cell lines (Nt-1
and Nt-2) was examined by COBRA during prolonged in vitro culture (P3, P10 and P30).
8. Effect of altered DNA methylation on pluripotency and disease
In humans, a growing number of reports suggest that children born following ART have an
increased risk of developing epigenetic diseases such as Beckwith-Wiedemann syndrome
[41,42] and Angelman Syndrome [43], which are caused by epigenetic modifications of im‐
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printed genes. In sheep, epigenetic changes in the Igf2r imprinted gene are associated with
fetal overgrowth after IVC [44]. Genome-wide altered DNA methylation also causes epige‐
netic diseases. For example, genome-wide DNA hypomethylation is commonly observed in
human cancers and schizophrenia, and occasionally induces tumors in mice [45-47]. More‐
over, hypomethylation in the classical DNA satellites II and III, which are major components
of constitutive heterochromatin, is found in ICF (immunodeficiency, centromeric instability,
facial anomalies) syndrome in humans [48].
How do these abnormalities in ES cells affect chimeric mice or ES cell-derived tissues? Sev‐
eral studies have indicated that the accumulation of epigenetic alterations during prolonged
culture causes a loss of pluripotency in ES cells [21,49]. In chimeras, prolonged culture of ES
cells gives rise to abnormalities and frequently results in postnatal death of chimeras pos‐
sessing a high ES cell contribution [20]. One reason for these problems could be that a loss of
imprinting enhances tumorigenesis. In fact, mice derived from ES cells that had a global loss
of DNA methylation display widespread cancer formation [50].
9. Candidate genes that cause altered DNA methylation
9.1. DNA methyltransferases
The most important factors for the maintenance of DNA methylation are the DNA meth‐
yltransferases.  Three  CpG DNA methyltransferases,  Dnmt1,  Dnmt3a and Dnmt3b,  coor‐
dinately regulate CpG methylation in the genome [12-14]. Deletion of Dnmt1, Dnmt3a or
Dnmt3b  induces  hypomethylation  of  genomic  DNA  [14,51],  and  forced  expression  of
Dnmts  causes  genomic  hypermethylation  [52-54].  One  of  the  Dnmt  family  members,
Dnmt3L, is not expressed in differentiated somatic cells but is expressed in ES cells.  Al‐
though Dnmt3L lacks the functional  domains required for  catalytic  activity,  overexpres‐
sion  or  downregulation  of  Dnmt3L  results  in  changes  in  DNA  methylation  in  ES  cells
[55]. Thus, the upregulation or downregulation of Dnmts could cause epigenetic instabili‐
ty in ES cells.  Indeed, hypomethylation in XX ES cells  is  associated with reduced levels
of Dnmt3a and Dnmt3b, which is the result  of both X chromosomes being in the active
state [25]. Among Dnmts, a number of alternative splicing variants that lack the regulato‐
ry and/or catalytic  regions have been reported.  In particular,  Dnmt3b has nearly 40 dif‐
ferent  isoforms generated by alternative splicing and/or  alternative promoter  usage.  We
recently  reported  that  murine  Dnmt3b  lacking  exon  6  (exon  5  in  human)  is  highly  ex‐
pressed in  in  vitro  manipulated embryos  and their  derivative  ES cells  that  exhibit  CpG
hypomethylation [17]. Gopalakrishnan et al. reported that this isoform is expressed in tu‐
mor  and iPS  cells,  and that  ectopic  overexpression resulted in  repetitive  element  hypo‐
methylation [56].  Similarly,  forced expression of  human specific  DNMT3B4,  which lacks
a  catalytic  domain,  induced DNA demethylation  on  satellite  2  in  pericentromeric  DNA
[57].  These  reports  indicate  that  Dnmts  have  complex  roles  in  the  maintenance  of  the
DNA methylation state. If this balance collapses, epigenetic instability will result.
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9.2. Other methylation factors
Other new methylation factors are Stella (PGC7) and Zfp57. Stella (PGC7), a primordial
germ cell and ES cell marker, protects against DNA demethylation in early embryogenesis
[58]. Zfp57, a putative KRAB zinc finger protein, is also required for the post-fertilization
maintenance of maternal and paternal methylation at multiple imprinted domains [59]. Re‐
ductions of the levels of these factors could induce hypomethylation of DNA in ES cells.
9.3. Active demethylation factors
Active DNA demethylation via the base excision repair pathway has recently been proposed
in mammals. In zebrafish, the coupling of a deaminase (activation-induced cytidine deami‐
nase, AID), a glycosylase (methyl-CpG binding domain protein 4, MBD4), and Gadd45 is in‐
volved in DNA demethylation [60]. In mammals, AID is indeed required for
reprogramming of the somatic cell genome by demethylation of pluripotency genes in ES-
somatic cell fusion [61]. Gadd45 also promotes epigenetic gene activation by repair-mediat‐
ed demethylation in mammals [28,29]. A Gadd45b gene is activated in Vitro ES cells that
possess hypomethylated imprinted genes and repetitive sequences [1]. Another recently
proposed demethylation pathway is the conversion of 5-methylcytosine (5-mC) to 5-hydrox‐
ymethylcytosine (5-hmC) mediated by the Ten-eleven translocation (TET) proteins, which
ultimately results in DNA demethylation [62-63]. In fact, the TET proteins (Tet1 and Tet2)
that regulate 5-hmC production [64] are abundantly expressed in ES cells and may be a
cause of epigenetic instability in ES cells.
9.4. Chromatin structure specific to ES cells
In ES cells, bivalent domains of chromatin, that regulate several key developmental genes,
contain both repressive (histone H3 lysine 27 methylation) and activating (histone H3 lysine
4 methylation) histone modifications that are usually mutually exclusive [65]. Bivalent do‐
mains silence developmental genes in ES cells while preserving their potential to become ac‐
tivated upon initiation of specific differentiation programs. DNA methylation was thought
to determine the chromatin structure; however, recent reports suggest that chromatin can af‐
fect DNA methylation and demethylation [66-67]. Therefore, bivalent chromatin modifica‐
tions specific to ES cells could be associated with DNA methylation instability.
10. Conclusion
ES cells exhibit instabilities in DNA methylation that are correlated with the origin of the
blastocysts from which they were derived (in vivo, in vitro, SCNT and uniparental), the cul‐
ture conditions, sex, and prolonged culture. Epigenotyping of ES cells should be adopted as
a prerequisite safety evaluation before their use in chimera production or therapeutic appli‐
cations. Furthermore, genes associated with aberrant DNA methylation should be moni‐
tored in ES cell lines to ensure that the cells do not accumulate epigenetic instabilities.
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Nomenclature
5-hmC, 5-hydroxymethylcytosine; 5-mC, 5-methylcytosine; AID, activation-induced cytidine
deaminase; COBRA, Combined bisulfite restriction analysis; DMR, differentially methylated
region; Dnmt, DNA methyltransferase; ES, embryonic stem; Gadd45, Growth arrest and
DNA damage-inducible protein 45; ICM, inner cell mass; IVC, in vitro culture; IVF, in vitro
fertilization; MBD4, methyl-CpG binding domain protein 4; PgES, parthenogenetic ES;
SCNT, somatic cell nuclear transfer; TET, Ten-eleven translocation; Vitro ES, ES cells de‐
rived from in vitro manipulated embryos; Vivo ES, ES cells derived from embryos devel‐
oped in vivo.
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